Saltoro Capital, LP Revance Therapeutics, Inc. Transaction History

Saltoro Capital, LP

  • $0
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$26.8 - $31.84 $616,400 - $732,320
-23,000 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$24.03 - $29.97 $432,540 - $539,460
18,000 Added 360.0%
23,000 $643,000
Q4 2020

Feb 16, 2021
BUY
$23.41 - $28.34 $117,050 - $141,700
5,000 New
5,000 $142,000

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Saltoro Capital, LP Portfolio

Follow Saltoro Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saltoro Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Saltoro Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email